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(PARP-1) plays a key role in the mechanisms responsible for neuronal
death. In the present study, we examined the effects of the PARP-1
inhibitor 3,4-dihydro-5-[4-1(1-piperidinyl)buthoxy]-1(2H)-isoquinoli-
none (DPQ) in two models of N-methyl-D-aspartate (NMDA)-induced
neurotoxicity. The exposure of mixed cultured cortical cells to 300 AM
NMDA for 10 min induced a caspase-dependent type of apoptotic
neuronal death. Conversely, exposure to 2 mM NMDA for 10 min led
to the appearance of morphological features of necrosis, with no
increase in caspase-3 activity and depletion in adenosine triphosphate
(ATP) levels. DPQ (10 AM) reduced the NMDA-induced PARP
activation, restored ATP to near control levels and significantly
attenuated neuronal injury only in the severe NMDA exposure model.
Similar results were obtained when pure neuronal cortical cultures
were used. PARP-1 activation thus appears to play a preferential role in
necrotic than in caspase-dependent apoptotic neuronal death.
D 2003 Elsevier Inc. All rights reserved.Introduction
Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme
that is primarily activated by DNA strand breaks. Upon activation,
the enzyme catalyzes the attachment of chains of poly(ADP-ribose)
(PAR) from its substrate h-nicotinamide adenine dinucleotide
(NAD) to a variety of nuclear proteins, including PARP-1 itself
(Chiarugi, 2002; Herceg and Wang, 2001; Smith, 2001). When
DNA damage is mild, PARP-1 is thought to be involved in the
maintenance of chromatin integrity. Conversely, overactivation of1044-7431/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.mcn.2003.09.016
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Available online on ScienceDirect (www.sciencedirect.com.)PARP-1 in response to massive DNA damage has been proposed to
play a ‘‘suicidal role’’ due to the marked depletion of NAD and
ATP tissue stores and the disruption of oxidative metabolism (Ha
and Snyder, 2000; Herceg and Wang, 2001; Szabo´ and Dawson,
1998). Accordingly, pharmacological PARP-1 inhibition decreases
tissue injury in conditions characterized by DNA stress such as
neurotoxicity, ischemia-reperfusion injury, diabetes, shock and
inflammation (Ha and Snyder, 2000; Szabo´ and Dawson, 1998;
Virag and Szabo, 2002). Moreover, targeted deletion of the PARP-
1 gene provides substantial neuroprotection in several experimental
models of acute injury (Burkart et al., 1999; Eliasson et al., 1997;
Endres et al., 1997; Mandir et al., 1999).
The intracellular depletion of ATP induced by PARP-1 over-
activation leads to energy failure and necrotic cell death (Ha and
Snyder, 1999; Moroni et al., 2001). In contrast, during the caspase-
dependent apoptotic process, PARP-1 is proteolytically cleaved
and inactivated by caspase-3, a process that is widely used as an
apoptotic marker (Oliver et al., 1998). PARP-1 cleavage in apo-
ptosis is thought to prevent ATP depletion by PARP-1 overactiva-
tion, thus affording the energy required for the apoptotic process.
Accordingly, the intracellular levels of ATP can regulate the mode
of cell death (Eguchi et al., 1997; Leist et al., 1997a): a depletion of
ATP, for example, has been demonstrated to shift apoptotic cell
death toward a necrotic process (Ha and Snyder, 1999). Recent
studies have shown that PARP-1 may also have a role in a caspase-
independent pathway of programmed cell death, by promoting the
release of apoptosis-inducing factor (AIF) from mitochondria
(Cregan et al., 2002; Yu et al., 2002). In this study, we character-
ized two models of N-methyl-D-aspartate (NMDA)-induced neu-
rotoxicity to investigate the role of PARP-1 and the effects of the
PARP-1 inhibitor 3,4-dihydro-5-[4-1(1-piperidinyl)buthoxy]-
1(2H)-isoquinolinone (DPQ) in apoptotic and necrotic neuronal
death. To this aim, we used mixed cortical cell cultures, containing
both glia and neurons, as well as pure neuronal cortical cultures,
exposed to NMDA under mild (10 min at 300 AM) or more intense
(20 min at 2 mM) conditions (Bonfoco et al., 1995). We show that
mild or intense NMDA exposure elicits apoptotic or necrotic
neuronal death, respectively. PARP-1 is activated at an early time
point in both models, but PARP-1 inhibition is effective only in
reducing necrotic neuronal death.
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Assessment of neuronal death following mild or intense NMDA
exposure in mixed cortical cell cultures
Mixed cortical cell cultures were evaluated at different time
points following NMDA exposure to determine the extent of
neuronal death. The release of LDH into the culture medium is a
known marker of neuronal injury that under these conditions
correlates with phase contrast cell observation and trypan blue
staining (Pellegrini-Giampietro et al., 1999a). Addition to the
medium of 300 AM NMDA for 10 min (mild insult) or 2 mM
NMDA for 20 min (intense insult) led to a time-dependent increase
in LDH release which was significant 6 h after the exposure (Fig.
1). Interestingly, 24 h after the mild NMDA insult, the amount of
LDH released was comparable to that observed after adding 100
nM staurosporine to the medium, a well-known apoptotic insult
that may lead to secondary necrosis and LDH efflux after pro-
longed (24 h) exposure in mixed cortical cultures (Koh et al., 1995;
Moroni et al., 2001). Neuronal damage induced by the larger
NMDA concentration was more extensive, and similar to that
observed with 1 mM glutamate for 24 h. This treatment induces
necrosis in virtually all neuronal cells but spares the underlying glial
cell layer (Moroni et al., 2001; Pellegrini-Giampietro et al., 1999a).
Caspase-3 activity, chromatin fragmentation and ATP levels in
mixed cortical cell cultures following mild or intense NMDA
exposure
The activation of caspase-3 may have a key role in the
initiation and the execution of neuronal apoptosis. To clarify theFig. 1. Neuronal injury induced by mild or intense NMDA exposure in
mixed murine cortical cultures. Cultures were exposed to 1 mM glutamate
for 24 h, 100 nM staurosporine for 24 h, 300 AM NMDA for 10 min (mild
exposure) or 2 mM NMDA for 20 min (intense exposure). Neuronal death
was assessed by measuring the release of LDH in the medium at the
indicated time after the initiation of exposure. Data are expressed as
percentage of control LDH release (31 F 6 units/l). Background LDH
release was determined in control sister cultures and was subtracted from all
experimental values. Both mild and intense NMDA exposure induced a
time-dependent increase in neuronal injury, whereas the long incubation
with the pro-apoptotic agent staurosporine produced a significant LDH
efflux that was presumably due to secondary necrosis. *P < 0.05 and **P <
0.01 vs. control (ANOVA + Tukey’s w test).type of neuronal death in our cultures, we measured the activity of
caspase-3 following mild or intense exposure to NMDA and under
conditions that are known to induce either necrotic or apoptotic
neuronal death in this system (Moroni et al., 2001). Exposure of
mixed cortical cultures to an intense excitotoxic and necrotic insult
such as 1 mM glutamate for 24 h induced no activation of
caspase-3, whereas 24 h exposure to the apoptotic agent staur-
osporine (100 nM) increased caspase-3 activity up to six times the
basal levels (Fig. 2A). Mild exposure to NMDA elicited a
transient but substantial increase in caspase-3 activity that was
maximal 6 h after the insult (Fig. 2A). In contrast, intense NMDA
exposure did not elicit a significant activation of caspase-3 at any
time point after the insult. The different effects of mild and intense
NMDA exposure were confirmed by morphological analysis of
neurons in mixed cultures stained with Hoechst 33258 under
fluorescence optics, which revealed typical apoptotic condensation
and fragmentation of chromatin only when cells were exposed to
100 nM staurosporine for 24 h (Fig. 2Bb) or 6 h after exposure to
300 AM NMDA for 10 min (Fig. 2Bc). Apoptotic chromatin
fragmentation was not observed when neurons were incubated
with 2 mM NMDA for 20 min (Fig. 2Bd). Under the latter
conditions, most neurons displayed round, small and highly
refringent nuclei, which is suggestive of necrotic cell death. A
quantitative analysis of chromatin-fragmented nuclei confirmed
that the number of apoptotic cells was significantly increased only
following exposure to 100 nM staurosporine for 24 or 6 h after
exposure to 300 AM NMDA (Fig. 2C), with a pattern that was
superimposable to that observed when caspase-3 activity was
measured (Fig. 2A).
Because ATP depletion is a feature of necrotic cell death, we
also measured the levels of ATP in cultures following mild or
intense NMDA exposure. The neuronal content of ATP was
significantly reduced 3 h after mild NMDA exposure, but it
returned toward basal levels at later time points (Fig. 3). In
contrast, a marked and time-dependent ATP depletion was ob-
served following intense NMDA exposure that reached a 96 F
4% reduction of basal levels 24 h after the insult. Glutamate
exposure induced a similar dramatic reduction, whereas stauro-
sporine produced only a slight and nonsignificant decrease in ATP
levels (Fig. 3).
Effects of the PARP inhibitor DPQ on neuronal death, caspase-3
activity, chromatin fragmentation and ATP levels in mixed cell and
pure neuronal cultures following mild or intense NMDA exposure
In this set of experiments, the PARP-1 inhibitor DPQ was
added at 10 AM to the incubation medium 10 min before exposing
cultured cells to NMDA. In mixed cortical cultures, DPQ reduced
neurotoxicity by 84 F 3% and 50 F 4% when LDH was measured
6 and 24 h, respectively, after exposure to 2 mM NMDA for 20
min, but was not neuroprotective against exposure to 300 AM
NMDA for 10 min (Fig. 4A). Similar results were obtained in pure
neuronal cultures. Although the reduction was not significant after
6 h, DPQ reduced neuronal death by 40 F 6% 24 h after the more
severe NMDA insult (Fig. 4B). We then examined the effects of
DPQ on caspase-3 activity, as detected 6 and 24 h after NMDA
exposure (Table 1). The PARP-1 inhibitor was unable to modify
caspase-3 activity in mixed cortical cells following mild or intense
NMDA insults, except for a slight but significant transient increase
in the enzyme activity that was observed 6 h after exposure to 2
Fig. 2. Caspase-3 activity and chromatin fragmentation are increased after mild but not intense NMDA exposure in mixed murine cortical cells. Cultures were
incubated with glutamate, staurosporine or NMDA as indicated in the legend to Fig. 1. (A) Caspase-3 activity was measured in the supernatant of lysed cells at
the indicated time after the initiation of exposure to drugs. Data are expressed as percentage of caspase-3 basal activity in control cells (16.1 F 2.5 pmol/106
cells) and represent the mean F SEM of at least five experiments. Staurosporine and 300 AM NMDA induced a massive caspase-3 activation, whereas no
significant activation was seen with glutamate or 2 mM NMDA. (B) Cultures were incubated with the nuclear dye Hoechst 33258 at the end of the exposure
period and photographed 10 min later under fluorescence optics. (a) Control cultures, displaying dispersed chromatin and evident nucleoli. (b) Neurons
incubated with 100 nM staurosporine for 24 h, exhibiting apoptotic nuclear fragmentation (arrow). (c) Six hours following 300 AM NMDA exposure for 10
min, neurons show extensive apoptotic nuclear fragmentation (arrow). (d) Six hours following 2 mM NMDA exposure for 20 min, neurons display mostly
small, brilliant and round-shaped nuclei (arrowhead), indicative of necrotic cell death. Scale bar = 15 Am. (C) Apoptotic nuclei (displaying fragmented
chromatin) were revealed by staining cells with Hoechst 33258 at the indicated time after the initiation of exposure to drugs. Apoptotic nuclei were counted in
three fields per well under a 40 magnification, averaged and expressed as mean F SEM number of apoptotic cells per field. Staurosporine and 300 AM
NMDA induced a significant increase in the number of apoptotic cells, whereas no significant increase was seen with glutamate or 2 mM NMDA. *P < 0.05
and **P < 0.01 vs. control (ANOVA + Tukey’s w test).
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number of chromatin-fragmented nuclei 6 h after exposing the
cultures to 2 mM NMDA for 20 min (Table 1). Also, in pure
neuronal cultures, DPQ induced a significant increase in caspase-3
activity 6 h after exposure to 2 mM NMDA (Table 2). Finally,
when we examined the effects of DPQ on the neuronal levels ofATP in mixed cortical cultures, the PARP-1 inhibitor had little
effect following exposure to 300 AM NMDA or 6 h after exposure
to 2 mM NMDA but restored the levels of ATP almost completely
(from 4 F 4% to 72 F 5% of control levels) 24 h after the intense
NMDA exposure (Fig. 5A). In pure neuronal cultures, the intra-
cellular content of ATP returned to near control levels (from 32 F
Fig. 3. Intracellular ATP levels in mixed murine cortical neurons following
mild or intense exposure to NMDA. Cultures were exposed to glutamate,
staurosporine or NMDA as indicated in the legend to Fig. 1. The contents of
ATP were evaluated in lysed cells at the indicated time after initiation of
exposure to drugs. The glial contribution to energy contents was measured
in sister cultures and subtracted to all experimental values. Data are
expressed as percentage of basal ATP content in control neurons (1160 F
90 Amol ATP/106 cells). The neuronal levels of ATP were significantly
reduced 3 h after mild NMDA exposure and almost completely depleted at
6 and 24 h after intense NMDA exposure. Each bar represents the mean F
SEM of at least six experiments. *P < 0.05 and **P < 0.05 vs. control
(ANOVA + Tukey’s w test).
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NMDA (Fig. 5B).
DPQ reduces early PARP activation in cultured cortical neurons
following intense and mild NMDA exposure
Because PAR immunoreactivity has been shown to be maximal
as early as 60 min following NMDA exposure (Yu et al., 2002), we
evaluated poly(ADP-ribosyl)ation in neurons present in mixed
cortical cultures at this time point following exposure to 300 AM
or 2 mM NMDA using a flow-cytometric assay. In control cortical
neurons, only a background peak at low levels of relative PAR
fluorescence intensity was observed (Fig. 6). Both mild and intense
NMDA exposure elicited the appearance of a second peak at higher
levels of relative PAR fluorescence intensity, indicative of an
increased PARP activity and increased formation of PAR (Fig.
6). This effect was significantly prevented by the addition of 10
AM DPQ to the incubation medium.Fig. 4. The PARP-1 inhibitor DPQ reduces neuronal death following
intense but not mild NMDA exposure in mixed (A) and pure neuronal (B)
murine cortical cultures. DPQ (10 AM) was added to the cultures 10 min
before NMDA exposure, which was performed as indicated in Fig. 1.
Neuronal death was assessed by measuring the release of LDH in the
medium at the indicated time after NMDA exposure. Data are expressed as
percentage of control LDH release and represent the mean F SEM of at
least five experiments. In pure neuronal cultures, LDH control release was
18 F 7 units/l. In both cultures, DPQ significantly decreased neuronal
injury only when it was induced by intense NMDA exposure. **P < 0.01
vs. NMDA exposure (ANOVA + Tukey’s w test).Discussion
Our study demonstrates that the presence in the incubation
medium of the PARP-1 inhibitor DPQ significantly attenuates
neuronal injury in mixed cortical neurons exposed to a more intense
but not to a milder NMDA exposure paradigm. Incubation with 2
mM NMDA for 20 min (intense insult) induced mostly necrotic
neuronal death in our cultures, whereas exposure to 300 AMNMDA
for 10 min (mild insult) displayed morphological and biochemical
signs of apoptotic neurodegeneration. Because DPQ was able to
reduce the activity of PARP-1 in both systems, these findings
suggest that PARP-1 overactivation may be an important mecha-nism leading to neuronal cell death of the necrotic but not of the
caspase-dependent apoptotic type. Because astrocytes may contrib-
ute to the neuroprotective effects of DPQ in mixed cortical cultures,
we also performed experiments using pure neuronal cultures. The
results of these experiments indicate that our observations in mixed
cultures primarily reflect activity in cortical neurons.
Necrosis and apoptosis are distinct mechanisms of cell death
with very different characteristics (Nicotera and Lipton, 1999;
Nicotera et al., 1999; Roy and Sapolsky, 1999). Markers of
apoptosis include cell shrinkage, membrane blebbing, chromatin
condensation and caspase activation, although a caspase-indepen-
dent form of apoptosis has recently been described (Cregan et al.,
2002; Yu et al., 2002). In this study, we were able to elicit either
caspase-dependent apoptosis or necrosis in cultured cortical cells
by adjusting the concentrations and the periods of exposure to the
excitotoxin NMDA. In a similar fashion, exposure of cortical
cultures to relatively short durations or low concentrations of
Table 2
Effects of the PARP-1 inhibitor DPQ on caspase-3 activity in pure murine
cortical neurons following mild or intense NMDA exposure
Caspase-3 activity
pmol/106 cells (%)
Control (24 h) 11.4 F 1.8 (100)
Mild Exposure
NMDA (6 h) 29.1 F 2.8* (255)
NMDA + DPQ (6 h) 30.3 F 2.5* (266)
Intense exposure
NMDA (6 h) 13.9 F 3.6 (122)
NMDA + DPQ (6 h) 20.5 F 2.2*,# (180)
Pure neuronal cultures were treated as indicated in the legend to Fig. 4.
Caspase-3 activity was evaluated in lysed cells 6 h after NMDA exposure.
Data represent the mean F SEM of at least three experiments. DPQ (10
AM) induced a significant increase in caspase-3 activity 6 h after the intense
NMDA insult.
*P < 0.01 vs. control.
# P < 0.05 vs. NMDA exposure (ANOVA + Tukey’s w test).
Table 1
Effects of the PARP-1 inhibitor DPQ on caspase-3 activity and chromatin
fragmentation in mixed murine cortical cells following mild or intense
NMDA exposure
Caspase-3 activity Apoptotic cells
pmol/106 cells (%) cells/field (%)
Control (24 h) 16.1 F 2.5 (100) 1.2 F 0.3 (100)
Mild Exposure
NMDA (6 h) 78.1 F 9.2** (485) 10.0 F 0.7** (933)
NMDA + DPQ (6 h) 76.3 F 7.0** (474) 9.3 F 1.9** (775)
NMDA (24 h) 30.6 F 7.0* (190) 3.4 F 0.8* (283)
NMDA + DPQ (24 h) 36.1 F 4.7* (224) 4.2 F 1.2* (350)
Intense exposure
NMDA (6 h) 38.3 F 15.8* (238) 1.3 F 1.0 (108)
NMDA + DPQ (6 h) 56.7 F 8.2**,# (352) 5.6 F 1.1*,# (466)
NMDA (24 h) 14.8 F 3.0 (92) 0.9 F 0.5 (75)
NMDA + DPQ (24 h) 15.3 F 4.0 (95) 1.5 F 0.4 (125)
Cultures were treated as indicated in the legend to Fig. 4. Caspase-3 activity
was evaluated in lysed cells at the indicated time after NMDA exposure.
Apoptotic nuclei displaying fragmented chromatin were revealed as
indicated in the legend of Fig. 2C. Data represent the mean F SEM of
at least five experiments. DPQ (10 AM) induced a significant increase in
caspase-3 activity and apoptotic neurons 6 h after the intense NMDA insult.
*P < 0.01 vs. control.
**P < 0.05 vs. control.
# P < 0.05 vs. NMDA exposure (ANOVA + Tukey’s w test).
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by apoptotic features, whereas intense exposure to high concen-
trations of NMDA triggered relatively rapid necrotic cell death
(Bonfoco et al., 1995). In another study, glutamate exposure was
able to induce either early necrosis or delayed apoptosis depending
on the mitochondrial function and cell energy supply (Ankarcrona
et al., 1995).
In pure neuronal cultures or in mixed cultures containing
neurons and astrocytes, the distinction between apoptosis and
necrosis may be difficult because of the poor presence of scav-
enging cells, such as microglia. Thus, the phagocytic step after
apoptosis may not occur and an apoptotic neuron can eventually
undergo secondary necrosis and rupture its contents into the
surrounding medium (Duke and Cohen, 1986). According to this
view, our results show that at late time points, both paradigms of
NMDA exposure led to the release of the cytoplasmic enzyme
LDH into the medium, indicating cell membrane leakage. Hence,
we examined other markers of apoptotic or necrotic cell death in
the cultures at various time points after the excitotoxic insult. Our
results show that following mild but not intense NMDA exposure,
there was a significant increase in the activity of caspase-3, which
may have a key role in the initiation and the execution of neuronal
apoptosis (Wang, 2000). In confirmation of earlier studies (Bon-
foco et al., 1995; Tenneti and Lipton, 2000), the elevation in
caspase-3 like protease activity occurred as early as 3 and 6 h after
mild NMDA exposure and was associated with an increase in the
number of chromatin-fragmented neurons at the same time points.
These changes were similar to those observed after prolonged
incubation with the pro-apoptotic PKC inhibitor staurosporine.
Twenty-four hours after mild NMDA exposure, caspase-3 activity
is somewhat reduced while ATP levels are still elevated in cultured
neurons. It is possible that apoptotic neurons at this late time point
may still possess abundant energy levels but are unable to proceedwith the neosynthesis of proteolytic enzymes. Because ATP is
required for the progression of apoptosis and its levels are
dissipated in necrosis (Leist et al., 1997a), the necrotic nature of
cell death following intense NMDA exposure in our cultures was
revealed not only by the absence of caspase-3 activation or nuclear
fragmentation, but also by the dramatic decrease in the neuronal
levels of ATP, which was similar to that observed following
incubation with high concentrations of glutamate.
PARP-1 inhibition with DPQ resulted in significant neuro-
protection only in the necrotic model of severe NMDA exposure,
but had no effect against apoptotic neuronal death following mild
NMDA exposure. These results are in line with previous literature
data showing that necrotic cell death is prevented by targeted
deletion of the PARP-1 gene or by pharmacological inhibition of
the enzyme, while apoptosis is unaffected (Ha and Snyder, 1999;
Moroni et al., 2001). PARP-1 deletion or inhibition have been
shown to attenuate cell injury in models in which the type of death
is predominantly necrotic, including cerebral (Eliasson et al., 1997;
Endres et al., 1997) and myocardial ischemia (Pieper et al., 2000),
and streptozotocin-induced diabetes (Burkart et al., 1999; Pieper et
al., 1999). In contrast, reduction of PARP activity does not protect
against killing of hepatocytes by TNF-a with actinomycin D or the
death of thymocytes elicited by ceramide, dexamethasone, CD-95
or ionomycin, which are forms of apoptotic cell death (Leist et al.,
1997b). Although PARP-1 activity is also known to affect cell
death and survival in a DNA-independent manner via the regula-
tion of transcription factors (Chiarugi, 2002; Ziegler and Oei,
2001), the finding that DPQ spares ATP in surviving neurons
exposed to the severe NMDA incubation, as previously demon-
strated in other cell types (Lee and Shacter, 1999), suggests that in
our necrotic model, PARP-1 is overactivated and leads to neuronal
death through the depletion of NAD and ATP cellular stores (the
so-called ‘‘suicidal role’’). In the milder model, PARP-1 cleavage
by caspase-3 activation facilitates apoptosis indirectly by prevent-
ing the energy failure induced by PARP-1 overactivation, thereby
preserving cellular ATP that is essential for the apoptotic process.
It is interesting to note that 6 h after intense NMDA exposure,
DPQ-pretreated cells exhibited a significant increase in caspase-3
like activity that was associated with an increase in the number of
Fig. 5. The PARP-1 inhibitor DPQ recovers ATP levels in mixed (A) and
pure neuronal (B) murine cortical cultures following intense but not mild
NMDA exposure. Cultures were treated as indicated in the legend to Fig. 4.
ATP levels were evaluated in lysed cells at the indicated time after NMDA
exposure. Data are expressed as percentage of basal ATP content in control
neurons and represent the meanF SEM of at least five experiments. In pure
neuronal cultures, ATP basal levels were 980 F 110 Amol ATP/106 cells. In
both cultures, DPQ almost completely prevented the reduction of ATP
observed 24 h after an intense NMDA insult. **P < 0.01 vs. NMDA
exposure (ANOVA + Tukey’s w test).
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inhibition and the subsequent recovery of ATP levels, there could
be a shift in the type of cell death, allowing some cells that would
have otherwise died by necrosis to die by apoptosis. According to
this view, previous studies have reported that the maintenance of
cellular energy levels induced by PARP-1 inhibition after injury
permits caspase activation and switches the type of cell death from
necrosis to apoptosis (Eguchi et al., 1997; Ha and Snyder, 1999;
Leist et al., 1997a; Walisser and Thies, 1999). The recovery of
energy levels induced by PARP-1 inhibition can also allow the
survival of some cells destined to die by apoptosis, as reported in
PC12 cells exposed to oxidative damage (Cole and Perez-Polo,
2002).
PARP-1 activity increases at early time points after neuronal
injury. The formation of PAR in the rat neocortex peaks at 30 min
and 2 h after experimental traumatic brain injury before returning
to baseline levels (LaPlaca et al., 1999). In cortical neurons
exposed to NMDA, PAR immunoreactivity can be revealed as
early as 15 min following NMDA exposure, with a maximum 1
h later (Yu et al., 2002). Therefore, we examined the extent of
poly(ADP-ribosyl)ation 1 h after mild or intense NMDA exposure
in this study and we observed that the neuronal formation of PARwas increased in a DPQ-sensitive manner in both models. These
findings confirm that PARP-1 may be transiently activated in the
early phases of apoptosis (Boulares et al., 1999; Simbulan-
Rosenthal et al., 1998; Scovassi and Poirier, 1999). Soon after,
however, the protein is cleaved and inactivated by caspase-3, thus
preventing ATP depletion by PARP-1 overactivation and afford-
ing the energy required for the apoptotic active process (Scovassi
and Poirier, 1999). This idea is supported by the early but
transient reduction in ATP levels following mild NMDA expo-
sure, that was soon after restored to levels similar to those
observed following prolonged incubation with the pro-apoptotic
PKC inhibitor staurosporine.
In conclusion, our results show that PARP-1 is activated at an
early time point in both models, but contributes significantly to the
necrotic cell death pattern observed after intense NMDA exposure
but not to the processes leading to apoptotic cell death following
mild NMDA exposure. These findings suggest that PARP-1
inhibitors may be of therapeutic importance in brain pathologies
where necrosis predominates.Experimental methods
Materials
NMDA and DPQ were purchased from Tocris Cookson (Bris-
tol, UK). Tissue culture reagents were obtained from GIBCO-BRL
(San Giuliano Milanese, MI, Italy) and ICN Pharmaceuticals
(Opera, MI, Italy). Lactate dehydrogenase (LDH) activity was
measured using the Cytotoxicity Detection Kit (LDH) from Roche
Italia (Monza, MI, Italy). Hoechst 33258 (bis-benzimide), propi-
dium iodide (PI), the EnzChekk Caspase-3 Assay Kit #2, the ATP
Determination Kit, the anti-glial fibrillary acidic protein (GFAP)
fluorescein isothiocyanate (FITC)-conjugated antibody and the
phycoerythrin-conjugated goat anti-rabbit IgG were purchased
from Molecular Probes Europe (Leiden, The Netherlands). Tergitol
(NP-40) was from Sigma-Aldrich (Milan, Italy). The polyclonal
antibody to PAR (LP96-10) was from Alexis Corp. Italia (Vinci,
FI, Italy).
NMDA neurotoxicity in cortical cell cultures
Cultures of mixed cortical cells containing both neuronal and
glial elements were prepared as previously described in detail
(Pellegrini-Giampietro et al., 1999a,b), used at 14 days in vitro
(DIV) and exposed at room temperature to 300 AM NMDA for 10
min (mild insult) or to 2 mM NMDA for 20 min (intense insult).
During NMDA exposure, the original culture medium [Eagle’s
Minimal Essential Medium (MEM, with Earle’s salts, glutamine-
and NaHCO3-free) supplemented with 38 mM NaHCO3, 22 mM
glucose, 100 units/ml penicillin, 100 Ag/ml streptomycin, 2 mM
glutamine, 10% heat-inactivated horse serum and 10% fetal bovine
serum] was replaced by thorough exchange with a HEPES con-
trolled salt solution (HCSS, composition in mM: 120 NaCl, 5.4
KCl, 0.8 MgCl2, 1.8 CaCl2, 20 HEPES, 15 glucose, 10 NaOH and
10 mg/l phenol red). After the exposure to NMDA, cultures were
rinsed with HCSS, the original medium was restored and cells were
kept at 37jC, 100% humidity and 95% air/5% CO2 atmosphere
until neurodegeneration was assessed. To achieve a maximal
degree of neuronal injury in this system, mixed cortical cultures
Fig. 6. DPQ reduces the early activation of PARP induced by intense and mild NMDA exposure in mixed murine cortical cells. Cultures were treated as
indicated in Fig. 4. One hour after NMDA exposure, cultures were fixed, labeled with antibodies directed against PAR and GFAP, and processed for flow
cytometry analysis. The GFAP-positive contribution to PAR fluorescence was subtracted from all samples. The graphs A and C plot the relative number of cells
displaying increasing levels of PAR fluorescence and are representative of four analyses. B and D show the percentage of PAR-positive cells in the entire
neuronal population, as calculated by counting the relative number of neurons detected at channels for high levels of PAR fluorescence (>350). Bars represent
mean F SEM of at least four experiments. Both mild and intense NMDA exposure elicited the formation of a high intensity PAR fluorescence peak in the
neuronal population, indicative of the neosynthesis of PAR, which was prevented by preincubation with DPQ. *P < 0.05 and **P < 0.01 vs. control; #P < 0.01
vs. control and P < 0.05 vs. NMDA challenge (ANOVA + Tukey’s w test).
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glutamate.
Pure neuronal cultures were prepared by seeding cortical cells
(resuspended in Neurobasalk medium with B-27 supplement,
GIBCO) onto poly-D-lysine-coated wells, used at 8–12 DIV and
exposed to mild or intense NMDA insult as described for mixed
cultures.
Cell damage was quantitatively evaluated in both cultures by
measuring the amount of LDH released from injured cells into the
extracellular fluid 24 h following exposure to NMDA, as previ-
ously described (Pellegrini-Giampietro et al., 1999a,b). Back-
ground LDH release was determined in control cultures not
exposed to NMDA and was subtracted from all experimental
values. The resulting value correlated linearly with the degree of
cell loss estimated by observation of cultures under phase-contrast
microscopy or under bright-field optics following 5 min incuba-
tion with 0.4% trypan blue, which stains debris and nonviable
cells.Measurement of caspase-3-like protease activity
The EnzChekk Caspase-3 Assay Kit # 2 was used to
measure increases in caspase-3 and other Asp-Glu-Val-Asp
(DEVD)-specific protease activities in cortical cultures. The assay
is based on the use of a bisamide derivative of rhodamine 110,
containing DEVD peptides covalently linked to each of the dye
amino groups, thereby suppressing its fluorescence. Upon enzy-
matic cleavage, the nonfluorescent bisamide substrate is con-
verted in a two-step process to rhodamine 110, which exhibits
fluorescent spectral properties similar to those of fluorescein.
Mixed cell or pure neuronal cortical cultures were harvested
and washed in phosphate-buffered saline. After brief centrifuga-
tion, cell pellets were resuspended in lysis buffer (Component C)
and incubated at 4jC for 30 min. Lysed cells were then
centrifuged (5 min at 5000 rpm) and the supernatants used to
detect caspase-3 proteolytic activity. The assay was performed by
adding 50 Al of reaction buffer (Component D, final concentra-
E. Meli et al. / Mol. Cell. Neurosci. 25 (2004) 172–180 179tion: 10 mM PIPES, pH 7.4, 2 mM EDTA, 5 mM dithiothreitol,
0.1% CHAPS and 50 AM benzyloxycarbonyl-DEVD-rhodamine
110 substrate) to 50 Al of the supernatants. After incubating the
samples at room temperature for 30 min, fluorescence was
measured with a fluorometer set at 496 nm excitation and 520
nm emission. Data were calculated as picomoles of rhodamine
110/106 cortical cells.
Microscopic analysis of cell necrosis and apoptosis
Nuclear morphological features of necrotic and apoptotic de-
generation were analyzed by fluorescence microscopy with the
nuclear dye Hoechst 33258 (bis-benzimide). Mixed cortical cells
were fixed with 4% paraformaldehyde for 30 min, washed in
phosphate-buffered saline and then incubated for 10 min at 37jC
with 1 Ag/ml Hoechst 33258. After washing in phosphate-buffered
saline (PBS), cells were viewed for nuclear chromatin morphology
in an Olympus IX50 fluorescence inverted microscope equipped
with an Olympus WU filter set (excitation: 330–385 nm) and a
40 or 60 objective. Normal cells were identified by intact
round-shaped nuclei with diffuse fluorescence and necrotic cells by
highly refringent smaller nuclei with uniformly dispersed chroma-
tin. Because nuclear condensation is a feature of both necrosis and
apoptosis, only cells displaying nuclear fragmentation and bleb-
bing were considered apoptotic. Fragmented apoptotic nuclei were
counted in three fields per well under a 40 magnification,
averaged and expressed as mean number of apoptotic cells per
field of at least five wells.
Measurement of ATP contents
Intracellular ATP was extracted from cells of mixed or pure
neuronal cortical cultures and measured by a luciferin-luciferase
bioluminescence assay (ATP Determination Kit). The assay is
based on luciferase’s requirement for ATP in producing light from
the reaction with luciferin. The whole cell population, including
glial cells in mixed cortical cultures, was subjected to the assay.
Cells were washed and collected in ice-cold PBS: 10 Al of the cell
lysate was added to 90 Al of working buffer containing 0.5 mM
luciferin, 1.25 Ag/ml luciferase, 25 mM Tricine buffer (pH 7.8), 5
mM MgSO4, 100 AM EDTA and 1 mM DTT. Luminescence was
analyzed after a 3-s delay with a luminometer (LKB-Wallac,
Turku, Finland). A standard curve was generated from known
concentrations of ATP in each experiment and used to calculate the
concentration of ATP in each sample. The glial contribution to
energy contents in mixed cortical cultures was evaluated in sister
cultures and subtracted to all samples. Data were calculated as
micromoles of ATP/106 cortical cells.
Measurement of PARP activity by flow cytometry
PARP activity was evaluated in mixed cortical cells exposed
to NMDA by cytofluorimetric measurement of PAR formation
according to Affar et al. (1999), with minor modifications. One
hour after NMDA exposure, neuronal cultures were detached
using 0.05% trypsin for 5 min at 37jC in PBS, washed with cold
PBS and fixed with 4% paraformaldehyde at room temperature.
Fixed cells were permeabilized with 0.2% NP-40, washed with
PBS, saturated with PBS-MT (PBS containing 5% nonfat pow-
dered milk and 0.1% Tween 20) for 1 h and then incubatedovernight at 4jC with anti-PAR (1:100) and FITC-conjugated
anti-GFAP (1:100) antibodies diluted in PBS-MT. After several
washes with PBS-MT, cells were incubated with a phycoerythrin-
conjugated anti-rabbit IgG (1:50) for 30 min. The cell suspension
(containing both neurons and astrocytes) was analyzed using a
flow cytometer (Coulter XL, Coulter Cytometry, Hialeah, FL,
USA). By means of appropriate electronic gates, neuron-related
events (PAR positive neurons) were sorted by subtracting FITC-
labeled cells (GFAP-positive astrocytes) from phycoerythrin-pos-
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